Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ZATA PHARMACEUTICALS, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2021-09-27 to 2023-09-26
Current total value of award: $12556731
Description: THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO EXERCISE OPTION PERIOD TWO (2)